{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:18:58Z","timestamp":1773458338026,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.npep.2009.12.011","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T05:55:00Z","timestamp":1263534900000},"page":"191-198","source":"Crossref","is-referenced-by-count":20,"title":["Contribution of the central dopaminergic system in the anti-hypertensive effect of kinin B1 receptor antagonists in two rat models of hypertension"],"prefix":"10.1016","volume":"44","author":[{"given":"H.","family":"De Brito Gariepy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Carayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2009.12.011_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/cs0820513","article-title":"Central bradykininergic system in normotensive and hypertensive rats","volume":"82","author":"Alvarez","year":"1992","journal-title":"Clin. Sci."},{"key":"10.1016\/j.npep.2009.12.011_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/CEH-100001193","article-title":"The dopaminergic system in hypertension","volume":"23","author":"Amenta","year":"2001","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.npep.2009.12.011_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2990.1982.tb00266.x","article-title":"Effects of haloperidol on cell proliferation in the early postnatal rat brain","volume":"8","author":"Backhouse","year":"1982","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.npep.2009.12.011_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1017\/S0958067000020960","article-title":"Transgenic animals in cardiovascular disease research","volume":"85","author":"Bader","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.npep.2009.12.011_bib5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S1567-5769(02)00175-3","article-title":"Structure of the mammalian kinin receptor gene locus","volume":"2","author":"Cayla","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/sj.bjp.0704632","article-title":"Pharmacologic and autoradiographic evidence for an up-regulation of kinin B(2) receptors in the spinal cord of spontaneously hypertensive rats","volume":"135","author":"Cloutier","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjp.0705759","article-title":"Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats","volume":"142","author":"Cloutier","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ejphar.2004.07.045","article-title":"Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus","volume":"500","author":"Couture","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib9","series-title":"Hand. Chem. Neuroanat. vol. 16: Peptide Receptors, Part 1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0924-8196(00)80009-3","article-title":"Brain kallikrein\u2013kinin system: from receptors to neuronal pathways and physiological functions","author":"Couture","year":"2000"},{"key":"10.1016\/j.npep.2009.12.011_bib10","unstructured":"De Brito Pereira, H., Couture, R., 2007. Brain tachykinin NK-3 receptors contribute to arterial hypertension through a dopaminergic mechanism. In: 38th Annual Meeting of Society for Neuroscience, November 3\u20137, San Diego, CA, USA, 2007 (P296.12)."},{"key":"10.1016\/j.npep.2009.12.011_bib11","unstructured":"De Brito Pereira, H., Talbot, S., Ongali, B., Couture, R., 2008. Role of kinin B1 receptor in the central autonomic control of blood pressure and body temperature in two rat models of hypertension. In: 39th Annual Meeting of the Society for Neuroscience, November 12\u201315, Washington, DC, USA, 2008 (P83.18)."},{"key":"10.1016\/j.npep.2009.12.011_bib12","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.2001.81.4.1599","article-title":"The hypothalamus and hypertension","volume":"81","author":"De Wardener","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2009.12.011_bib13","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjp.0706249","article-title":"The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation","volume":"145","author":"Deschamps","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/sj.bjp.0707388","article-title":"The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance","volume":"152","author":"Dias","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib15","unstructured":"Dias, J.P., Talbot, S., Pilon, M., S\u00e9n\u00e9cal, J., de Champlain, J., Ferrari, B., Carayon, P., Couture, R., 2009. Kinin B1 receptor as a therapeutic target in the treatment of diabetes. In: The Fifth International Symposium on Peptide Receptors and Kinin 2009, June 26\u201330, Quebec, Canada (P28)."},{"key":"10.1016\/j.npep.2009.12.011_bib16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.bjp.0702527","article-title":"The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats","volume":"126","author":"Emanueli","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1124\/jpet.103.059527","volume":"309","author":"Gougat","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2009.12.011_bib18","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.2174\/138161206778559614","article-title":"Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals","volume":"12","author":"Hashimoto","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2009.12.011_bib19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2008.05.006","article-title":"Blockade of sensory abnormalities and kinin B1 receptor expression by N-acetyl-l-cysteine and ramipril in a rat model of insulin resistance","volume":"589","author":"Ismael","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib20","first-page":"10","article-title":"Role of dopamine in the pathogenesis of hypertension","volume":"26","author":"Jose","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol. Suppl."},{"key":"10.1016\/j.npep.2009.12.011_bib21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00004872-199310000-00006","article-title":"Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats","volume":"11","author":"Khan","year":"1993","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2009.12.011_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/01.HYP.25.4.524","article-title":"Brain kallikrein\u2013kinin system abnormalities in spontaneously hypertensive rats","volume":"25","author":"Khan","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2009.12.011_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-4522(93)90188-L","article-title":"Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis","volume":"52","author":"Kirouac","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2009.12.011_bib24","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00004872-200305000-00017","article-title":"NAD(P)H oxidase activation by angiotensin II is dependent on p42\/44 ERK\u2013MAPK pathway activation in rat\u2019s vascular smooth muscle cells","volume":"21","author":"Laplante","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2009.12.011_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2009.12.011_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/sj.bjp.0705042","article-title":"Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study","volume":"138","author":"Lessard","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2003.12.013","article-title":"Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat","volume":"486","author":"Lessard","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib28","first-page":"H2489","article-title":"Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats","volume":"266","author":"Lin","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2009.12.011_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(94)91739-6","article-title":"The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats","volume":"639","author":"Linthorst","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2009.12.011_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.npep.2007.09.005","article-title":"Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance","volume":"41","author":"Lungu","year":"2007","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2009.12.011_bib31","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/j.1476-5381.1991.tb12341.x","article-title":"Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin","volume":"103","author":"Martins","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3565(24)37777-8","volume":"287","author":"Millan","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2009.12.011_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2009.12.011_bib34","doi-asserted-by":"crossref","first-page":"H1949","DOI":"10.1152\/ajpheart.01113.2002","article-title":"Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord","volume":"284","author":"Ongali","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2009.12.011_bib35","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.peptides.2005.03.047","article-title":"Effects of alpha-lipoic acid on kinin B1 and B2 receptor binding sites in the spinal cord of chronically angiotensin-treated rats","volume":"26","author":"Petcu","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2009.12.011_bib36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1139\/y02-051","article-title":"Kinin B1 and B2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats","volume":"80","author":"Qadri","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2009.12.011_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1515\/BC.2001.005","article-title":"Classification of kinin receptors","volume":"382","author":"Regoli","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.npep.2009.12.011_bib38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2174\/1381612053507422","article-title":"Targeting kinin receptors for the treatment of neurological diseases","volume":"11","author":"Rodi","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2009.12.011_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1440-1681.1997.tb02129.x","article-title":"Pressor responses to brain dopaminergic stimulation","volume":"24","author":"van den Buuse","year":"1997","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2009.12.011_bib40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/10641969109042068","article-title":"Role of brain dopamine systems in the development of hypertension in the spontaneously hypertensive rats","volume":"13","author":"van den Buuse","year":"1991","journal-title":"Clin. Exp. Hypertens. A"},{"key":"10.1016\/j.npep.2009.12.011_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-0102(99)00037-1","article-title":"Brain dopamine D2 receptor mRNA levels are elevated in young spontaneously hypertensive rats","volume":"34","author":"Vaughan","year":"1999","journal-title":"Neurosci. Res."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417909001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417909001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T19:35:46Z","timestamp":1739734546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417909001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0143417909001504"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2009.12.011","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}